LANGE LOUIS G bought NAMS
January 7, 2026 · Form 4 insider transaction
LANGE LOUIS G bought 15,300 shares of NewAmsterdam Pharma Company N.V. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,300
Price
$0.00
Total value
N/A
InsiderLANGE LOUIS G
RoleDirector
SecurityOption (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 7, 2026
Filing dateJanuary 9, 2026
Shares owned after15,300
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
All of the ordinary shares underlying the option will vest on January 2, 2027, the one-year anniversary of the vesting start date, subject to the Reporting Person's continued service through such date.